Shameze Rampertab
CFO
Profound Medical Corp.,
T: 647.476.1350, Ext. 424
Ad Statistics
Times Displayed: 22281
Times Visited: 445 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
srampertab@profoundmedical.com
Or
Rebecca von Goetz
Senior Marketing & Communications Specialist
Profound Medical Corp.,
T: 647.476.1350, Ext. 426
C: 416.917.8650
rvongoetz@profoundmedical.com
For Philips media inquiries, please contact:
Steve Klink
Press Officer
Royal Philips
T: 31610888824
steve.klink@philips.com
About Profound Medical Corp.
Profound Medical is a Canadian medical device company that has developed a unique and minimally invasive treatment to ablate the prostate gland. Profound’s novel technology combines MRI technology with ultrasound thermal energy that is delivered via a transurethral approach. This method of prostate cancer therapy provides highly accurate and precise treatment within the prostate in a short time span, allowing for fast patient recovery. The potential of this technology is currently being demonstrated in clinical trials. For more information, visit profoundmedical.com
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a diversified health and well-being company, focused on improving people's lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle and Lighting. Headquartered in the Netherlands, Philips posted 2014 sales of EUR 21.4 billion and employs approximately 108,000 employees with sales and services in more than 100 countries. The company is a leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as male shaving and grooming and oral healthcare. News from Philips is located at www.philips.com/newscenter.
Back to HCB News
